Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - TOTAL CURRENT ASSETS
Total Current Assets APLS - Apellis Pharmaceuticals, Inc.
766 M
LAST VALUE
-3.57%
2 YEAR CAGR
30.50%
5 YEAR CAGR
64.79%
10 YEAR CAGR